Michael Joshua Bennefield, NPC

Michael Bennefield practices at Archbold Memorial in Thomasville, Georgia, part of Archbold.

Michael Bennefield's NPI, 1902510076, was assigned on January 12, 2023. Michael Bennefield holds Georgia license RN282668.

Michael Bennefield's primary practice is Archbold Memorial, at 915 Gordon Avenue & Mimosa Drive, Thomasville, GA 31792 in Thomas County. The practice phone is (229) 228-2880.

Michael Bennefield's primary practice is Archbold Memorial in Thomasville, Georgia, part of Archbold. The medical group on file is TMH Physician Partners. Dmand AI also links Michael Bennefield to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Bennefield practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Michael Bennefield's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Michael Bennefield is board certified in ccrn by the AACN. Michael Bennefield is licensed in Georgia.

CMS data shows 27 Medicare services from Michael Bennefield across 1 procedure code in 2024, for 60 Medicare patients. Medicare paid $1,343 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Michael Bennefield in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Bennefield's median patient age at 71, with 52% women.

In 2024, Michael Bennefield wrote 18 Medicare Part D claims. 100% of them were for generic drugs.

Michael Bennefield accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Michael Bennefield from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $79.